Katelyn Berteletti

Katelyn Berteletti is a seasoned professional in clinical operations with extensive experience spanning over a decade. Currently serving as Director of Clinical Operations at Novo Nordisk since January 2022, Katelyn has held significant roles at Dicerna Pharmaceuticals, Inc., resTORbio, Spero Therapeutics, Akebia Therapeutics, and the Harvard Clinical Research Institute. Katelyn's career in clinical operations began with clinical project management and regulatory coordination, culminating in a diverse portfolio that demonstrates strong leadership and expertise in clinical research. Katelyn earned a Bachelor of Arts in History from Trinity College-Hartford in 2009.